Literature DB >> 19249737

Present status and future perspectives of preoperative portal vein embolization.

Hai Liu1, Shaihong Zhu.   

Abstract

BACKGROUND: Portal vein embolization (PVE) has been gaining increasing acceptance before major hepatectomy. This review presents the application, outcome, and recent developments of PVE.
METHODS: After a systematic search of "portal vein embolization" in PubMed, we reviewed and retrieved articles written in English related to PVE. There were no other criteria for exclusion of published information pertaining to this topic.
RESULTS: Hypertrophy of future liver remnants with PVE in patients with hepatobiliary malignancy results in fewer complications and shorter hospital stays after major hepatectomy, and add to the pool of candidates for surgical treatment. Some new techniques, such as sequential hepatic artery-portal vein embolization and PVE with stem cell administration, have showed a promising clinical future.
CONCLUSIONS: PVE has achieved significant improvement in the outcome of major hepatectomy, and has enlarged the candidate pool of liver resection as well. Future study is needed to identify the precise mechanism of liver regeneration after PVE.

Entities:  

Mesh:

Year:  2009        PMID: 19249737     DOI: 10.1016/j.amjsurg.2008.04.022

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  36 in total

1.  Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation.

Authors:  Hiroya Iida; Tsukasa Aihara; Shinichi Ikuta; Hidenori Yoshie; Naoki Yamanaka
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

2.  Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis.

Authors:  Kristopher P Croome; Roberto Hernandez-Alejandro; Maile Parker; Julie Heimbach; Charles Rosen; David M Nagorney
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

Review 3.  Liver function impairment in liver transplantation and after extended hepatectomy.

Authors:  Matteo Serenari; Matteo Cescon; Alessandro Cucchetti; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 4.  Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases.

Authors:  Fernando A Alvarez; Rodrigo Sanchez Claria; Sebastian Oggero; Eduardo de Santibañes
Journal:  World J Gastrointest Surg       Date:  2016-06-27

5.  Hypertrophy of the Left Liver in Patients with Large Tumors in the Right Liver.

Authors:  Yoshimi Nakayama; Yoichi Ishizaki; Jiro Yoshimoto; Hiroyuki Sugo; Hiroshi Imamura; Seiji Kawasaki
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

6.  How to avoid postoperative liver failure: a novel method.

Authors:  Eduardo de Santibañes; Fernando A Alvarez; Victoria Ardiles
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

7.  Is there new hope for patients with marginally resectable liver malignancies.

Authors:  Martin Loos; Helmut Friess
Journal:  World J Gastrointest Surg       Date:  2012-07-27

8.  Clinical feasibility of inferior right hepatic vein-preserving trisegmentectomy 5, 7, and 8 (with video).

Authors:  Sung Hoon Choi; Gi Hong Choi; Dai Hoon Han; Jin Sub Choi; Woo Jung Lee
Journal:  J Gastrointest Surg       Date:  2013-01-29       Impact factor: 3.452

9.  Massive hepatic necrosis with toxic liver syndrome following portal vein ligation.

Authors:  Aurélien Dupré; Johan Gagnière; Lucie Tixier; David Da Ines; Sébastien Perbet; Denis Pezet; Emmanuel Buc
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

Review 10.  A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Authors:  Jin-Yao Teo; John C Allen; David C Ng; Su-Pin Choo; David W M Tai; Jason P E Chang; Foong-Khoon Cheah; Pierce K H Chow; Brian K P Goh
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.